Pharmacoepidemiological analysis of insulin medications on the pharmaceutical market of Ukraine
DOI:
https://doi.org/10.24959/uekj.20.6Keywords:
diabetes mellitus, insulin, pharmaceutical market of UkraineAbstract
Diabetes mellitus morbidity is increasing all over the world. According to WHO, by 2030, diabetes will be the seventh leading cause of death worldwide. This disease acquires the status of non-infectious epidemic. This way, insulin therapy requires the use of effective and economically justified therapy in the limited financing of healthcare.
Aim. To use ATС/DDD methodology for pharmacoepidemiological analysis of insulin medications.
Results. As a result of the frequency analysis of insulin preparations on the pharmaceutical market ofUkraine in 2019, 71 trade names have been discovered. Domestic drugs – 58 % and foreign drugs – 42 %. Manufacturers of countries such asPoland,Denmark,Germany,France, theNetherlands supply insulin preparations to the Ukrainian pharmaceutical market. ATC/DDD-methodology showed that the cost for DDD was in the range from 8.13 to 63.02 UAH in the context of minimal and maximal prices of insulin preparations.
Conclusions. It has been found that the minimum cost of DDD insulin preparations was 8.13 UAH, the maximum – 63.02 UAH.References
IDF Diabets atlas seventh edition. (2015). Available at: http://www.idf.org/diabetesatlas
Nakaz MOZ Ukrainy vid 21.12.2012 r. № 1118. (2012). Unifikovanyi klinichnyi protokol pervynnoi ta vtorynnoi (spetsializovanoi) medychnoi dopomohy. Available at: https://www.moz.gov.ua/docfiles/dod1118_2_2012.pdf
Ivko, T. I., Hermaniuk, T. A. (2015). Optymizatsiia likarskoho zabezpechennia khvorykh na tsukrovyi diabet 2 typu na osnovi farmakoekonomichnykh doslidzhen: metod. rekom. Kyiv: Ukrainskyi tsentr naukovoi medychnoi informatsii ta patentno-litsenziinoi roboty, 30.
Nemchenko, A. S., Zhyrova, I. V. (2002). Metodolohichni aspekty farmakoekonomiky. Klinichna farmatsiia, 2, 4–8.
Iakovlieva, L. V., Bezditko, N. V., Gerasymova, O. O., Mishchenko, O. Ya., Karbusheva, I. V., Tkachova, O. V., Berkalo, N. N. (2009). Farmakoekonomika: navchalnyi posibnyk dlia studentiv vyshchykh navchalnykh zakladiv. Vinnytsia: Nova knyha, 207.
Zaliska, O. M., Parnovskoho, B. L. (Eds.). (2007). Farmakoekonomika: navch. posibnyk dlia provizoriv-interniv, slukhachiv pisliadyplomnoi osvity. Lviv: Afisha, 374.
Boiko, A. I. (2006). Marketynhovi ta farmakoekonomichni doslidzhennia likarskykh zasobiv dlia likuvannia diabetu. Extended abstract of candidate’s thesis. Lviv, 22.
Hremb, O. Yu. (2007). Optymizatsiia farmatsevtychnoi dopomohy khvorym na tsukrovyi diabet 2 typu (model diialnosti klinichnoho provizora). Extended abstract of candidate’s thesis. Lviv, 25.
Ivko, T. I., Hermaniuk, T. A., Prudyus, P. H., Flaksemberh, A. S., Hirniak, M. Ya. (2015). Vybir ratsionalnoi skhemy terapii khvorykh na tsukrovyi diabet 2 typu na osnovi analizu vytraty-efektyvnist : inform. lyst. Kyiv: Ukrainskyi tsentr naukovoi medychnoi informatsii ta patentno-litsenziinoi roboty, 4.
Yahudyna, R. Y., Kulykov, A. Yu., Arynyna, E. E. (2011). Farmakoekonomyka sakharnoho dyabeta vtoroho typa. Moscow: OOO “Medytsynskoe ynformatsyonnoe ahentstvo”, 4–66.
Vlasenko, M. V. (2013). Tsukrovyi diabet: diahnostyka i monitorynh. Liky Ukrainy, 9-10, 17–18.
Data of the state register of medicines. (n.d.). Available at: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument
WHOCC-ATC / DDD Index. (n.d.). Available at: http://www.whocc.no/atc_ddd_index
Data of the state register of wholesale-selling prices at 30.11.2018. (2018). Available at: https://pharmbase.com.ua/ru/optovye-predlozheniya
Downloads
Published
Issue
Section
License
Copyright (c) 2020 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
